ICTUImperial Clinical Trials Unit

Welcome to Imperial Clinical Trials Unit (ICTU)

This website is intended for commercial trial sponsors engaged in the area of pharmaceuticals, medical devices or diagnostic devices


ICTU is currently involved in three respiratory trials led by Investigators at Imperial College and the Royal Brompton and Harefield NHS Foundation Trust. The areas of research are: asthma, cystic fibrosis and interstitial lung disease.

AZALEA: A Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Oral Azithromycin (500 mg OD) as a Supplement to Standard Care for Adult Patients with Acute Exacerbations of Asthma

RECITAL: A randomised, double blind controlled trial comparing Rituximab against intravenous Cyclophosphamide in Connective Tissue Disease (CTD) associated Interstitial Lung Disease (ILD):

Repeated application of gene therapy in Cystic Fibrosis patients